Your browser doesn't support javascript.
loading
Survival and late mortality among patients who survived disease-free for 2 years after stem cell transplantation.
Wu, Linnan; Wu, Yibo; Shi, Jimin; Lai, Xiaoyu; Zhao, Yanmin; Liu, Lizhen; Yu, Jian; Yang, Luxin; Zhu, Panpan; Zheng, Weiyan; Hu, Yongxian; Wu, Wenjun; Zhu, Yuanyuan; Cai, Zhen; Huang, He; Luo, Yi.
Afiliación
  • Wu L; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Wu Y; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.
  • Shi J; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Lai X; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Zhao Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Liu L; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.
  • Yu J; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Yang L; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Zhu P; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zheng W; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.
  • Hu Y; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Wu W; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Zhu Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Cai Z; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.
  • Huang H; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Luo Y; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
Br J Haematol ; 202(3): 608-622, 2023 08.
Article en En | MEDLINE | ID: mdl-37306071

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Neoplasias Hematológicas / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Br J Haematol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Neoplasias Hematológicas / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Br J Haematol Año: 2023 Tipo del documento: Article País de afiliación: China